For more information please contact:
Equity Capital Markets
Head of Equity
Senior Vice President
Senior Vice President
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, has closed its initial public offering of 1,875,000 shares of common stock at a price of $8.00 per share. The common stock is trading on the NASDAQ Capital Market under the symbol "SNES".
ROTH Capital Partners acted as Sole Book-Running Manager in the transaction.
About SenesTech, Inc.
SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product candidate, ContraPest®, will be marketed for use initially in controlling rat infestations. Senestech currently has no revenues and is beginning commercialization of ContraPest.
Senestech believes its non-lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is currently no other non-lethal fertility control product approved by the Food and Drug Administration (FDA), or the Environmental Protection Agency (EPA), for the management of rodent populations. Senestech believes that ContraPest® will establish a new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative environmental effects of rodenticides. For more information, visit
www.senestech.com. (Source: Company
Press Release | 12/13/16)
About ROTH Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. For more information on ROTH, please visit